Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoki Todo

Showing results (41-50 of 96) with videos related to

Pageof 10
Sort By:
British Journal of Haematology|April 27, 2011
Temozolomide may induce therapy-related acute lymphoblastic leukaemiaMizuki Ogura, Tomoki Todo, Minoru Tanaka, et al.
Cancer Research|March 3, 2016
Identification of RNA-Binding Protein LARP4B as a Tumor Suppressor in GliomaHideto Koso, Hungtsung Yi, Paul Sheridan, et al.
Scientific Reports|April 20, 2017
The role of the SWI/SNF chromatin remodeling complex in maintaining the stemness of glioma initiating cellsHiroaki Hiramatsu, Kazuyoshi Kobayashi, Kyousuke Kobayashi, et al.
The Journal of Biological Chemistry|October 12, 2011
Glioma-initiating cells retain their tumorigenicity through integration of the Sox axis and Oct4 proteinHiroaki Ikushima, Tomoki Todo, Yasushi Ino, et al.
British Journal of Haematology|November 20, 2020
Oncolytic herpes simplex virus type 1 (HSV-1) in combination with lenalidomide for plasma cell neoplasmsMaki Oku, Ryo Ishino, Shumpei Uchida, et al.
Neurosurgery|July 1, 2005
Functional monitoring for visual pathway using real-time visual evoked potentials and optic-radiation tractographyKyousuke Kamada, Tomoki Todo, Akio Morita, et al.
Oncotarget|January 7, 2020
Efficacy of a third-generation oncolytic herpes simplex virus in neuroendocrine tumor xenograft modelsHideyuki Matsushima, Masaki Kaibori, Masahiko Hatta, et al.
Brain and Nerve = Shinkei Kenkyu No Shinpo|March 16, 2007
[Advances in neuroscience and therapeutic research on neurological diseases--the present status and future prospects (discussion)]Shoji Tsuji, Tadashi Isa, Tadafumi Kato, et al.
Cancer|December 20, 2011
Extended field stereotactic radiosurgery for recurrent glioblastomaTomoyuki Koga, Keisuke Maruyama, Minoru Tanaka, et al.
Molecular Therapy Oncolytics|January 9, 2023
Overcoming resistance of stroma-rich pancreatic cancer with focal adhesion kinase inhibitor combined with G47Δ and immune checkpoint inhibitorsTomoharu Yamada, Ryosuke Tateishi, Miwako Iwai, et al.
Pageof 10

Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
British Journal of Haematology|April 27, 2011
Temozolomide may induce therapy-related acute lymphoblastic leukaemiaMizuki Ogura, Tomoki Todo, Minoru Tanaka, et al.
Cancer Research|March 3, 2016
Identification of RNA-Binding Protein LARP4B as a Tumor Suppressor in GliomaHideto Koso, Hungtsung Yi, Paul Sheridan, et al.
Scientific Reports|April 20, 2017
The role of the SWI/SNF chromatin remodeling complex in maintaining the stemness of glioma initiating cellsHiroaki Hiramatsu, Kazuyoshi Kobayashi, Kyousuke Kobayashi, et al.
The Journal of Biological Chemistry|October 12, 2011
Glioma-initiating cells retain their tumorigenicity through integration of the Sox axis and Oct4 proteinHiroaki Ikushima, Tomoki Todo, Yasushi Ino, et al.
British Journal of Haematology|November 20, 2020
Oncolytic herpes simplex virus type 1 (HSV-1) in combination with lenalidomide for plasma cell neoplasmsMaki Oku, Ryo Ishino, Shumpei Uchida, et al.
Neurosurgery|July 1, 2005
Functional monitoring for visual pathway using real-time visual evoked potentials and optic-radiation tractographyKyousuke Kamada, Tomoki Todo, Akio Morita, et al.
Oncotarget|January 7, 2020
Efficacy of a third-generation oncolytic herpes simplex virus in neuroendocrine tumor xenograft modelsHideyuki Matsushima, Masaki Kaibori, Masahiko Hatta, et al.
Brain and Nerve = Shinkei Kenkyu No Shinpo|March 16, 2007
[Advances in neuroscience and therapeutic research on neurological diseases--the present status and future prospects (discussion)]Shoji Tsuji, Tadashi Isa, Tadafumi Kato, et al.
Cancer|December 20, 2011
Extended field stereotactic radiosurgery for recurrent glioblastomaTomoyuki Koga, Keisuke Maruyama, Minoru Tanaka, et al.
Molecular Therapy Oncolytics|January 9, 2023
Overcoming resistance of stroma-rich pancreatic cancer with focal adhesion kinase inhibitor combined with G47Δ and immune checkpoint inhibitorsTomoharu Yamada, Ryosuke Tateishi, Miwako Iwai, et al.
Pageof 10